Does Rallies show 13F holders for GEHC?

Yes. Rallies tracks hedge fund and 13F ownership data for GEHC, including fund names, share counts, latest tracked quarter, and position changes when available.

Is GEHC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GEHC. It does not provide personalized investment advice.

GEHC (GE HealthCare Technologies Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

GE HealthCare Technologies Inc. Common Stock (GEHC) is a publicly traded Healthcare sector company. As of May 20, 2026, GEHC trades at $64.01 with a market cap of $27.98B and a P/E ratio of 15.35. GEHC moved +4.35% today. Year to date, GEHC is -24.44%; over the trailing twelve months it is -10.56%. Its 52-week range spans $57.65 to $94.80. Analyst consensus is buy with an average price target of $82.36. Rallies surfaces GEHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns GEHC stock?

Hedge funds tracked by Rallies that own GEHC include Harris Associates, Temasek Holdings, D1 Capital, Cooperman Leon, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for GE HealthCare Technologies Inc. Common Stock.

GEHC Key Metrics

Key financial metrics for GEHC
Metric	Value
Price	$64.01
Market Cap	$27.98B
P/E Ratio	15.35
EPS	$4.18
Dividend Yield	0.04%
52-Week High	$94.80
52-Week Low	$57.65
Volume	6.48M
Avg Volume	0
Revenue (TTM)	$20.98B
Net Income	$1.98B
Gross Margin	39.15%

Top Hedge Funds Holding GEHC

Harris Associates holds 15.59M shares of GEHC, changed -1.64% as of Mar 31, 2026.
Temasek Holdings holds 3.26M shares of GEHC, changed +147.39% as of Mar 31, 2026.
D1 Capital holds 1.76M shares of GEHC, changed +77.29% as of Dec 31, 2025.
Cooperman Leon holds 670.00K shares of GEHC, changed +0.00% as of Mar 31, 2026.
Pinebridge Investments holds 121.19K shares of GEHC, changed -44.35% as of Jun 30, 2025.

Latest GEHC News

Ventripoint Files AI Cardiac Imaging to NMPA, Exhibits at AEPC Congress — May 19, 2026
GE HealthCare Cuts 2026 EPS Guidance to $4.80-$5.00, Shares Plunge 13% — May 1, 2026
GE HealthCare plunges as Q1 EPS miss triggers 2026 guidance cut on cost pressures — Apr 30, 2026
GE HealthCare Lowers 2026 EPS to $4.80–$5.00 After Q1 EPS Miss — Apr 29, 2026
GE HealthCare Shares Fall 6% After Q1 EPS Miss, Full-Year EPS Cut to $4.80–$5.00 — Apr 29, 2026

Recent GEHC Insider Trades

Hochman Rodney F bought 1.62K (~$100.36K) on May 12, 2026.
Yang Watkin Phoebe L. bought 1.00K (~$63.01K) on May 8, 2026.
CULP H LAWRENCE JR bought 80.81K (~$5.00M) on May 6, 2026.

GEHC Analyst Consensus

12 analysts cover GEHC: 0 strong buy, 8 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $82.36.

Common questions about GEHC

Who owns GEHC stock?: Hedge funds tracked by Rallies that own GEHC include Harris Associates, Temasek Holdings, D1 Capital, Cooperman Leon, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for GE HealthCare Technologies Inc. Common Stock.
Does Rallies show 13F holders for GEHC?: Yes. Rallies tracks hedge fund and 13F ownership data for GEHC, including fund names, share counts, latest tracked quarter, and position changes when available.
Is GEHC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GEHC. It does not provide personalized investment advice.